Deferasirox Tablet, For Suspension
Product Images NDC 68462-494

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Deferasirox (NDC 68462-494). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lbl125mg30s.jpg (Lbl125mg30s)

Lbl125mg30s.jpg (Lbl125mg30s)
Deferasirox is a medication with NDC code 68462-494-30. The rest of the text contains jumbled characters and does not provide any useful information.*
FDA Label Image

Lbl250mg30s.jpg (Lbl250mg30s)

FDA Label Image

Lbl500mg30s.jpg (Lbl500mg30s)

FDA Label Image

Structure.jpg (Structure)

FDA Label Image

Figure1.jpg (Figure1)

FDA Label Image

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.